Mutations in the met Oncogene Unveil a “Dual Switch” Mechanism Controlling Tyrosine Kinase Activity
Open Access
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (31) , 29352-29358
- https://doi.org/10.1074/jbc.m302404200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomasOncogene, 2000
- Novel mutations of the MET proto-oncogene in papillary renal carcinomasOncogene, 1999
- Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumoursOncogene, 1998
- Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasNature Genetics, 1997
- The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro.Molecular Biology of the Cell, 1996
- Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb budNature, 1995
- Scatter factor/hepatocyte growth factor is essential for liver developmentNature, 1995
- Processing of hepatocyte growth factor to the heterodimeric form is required for biological activityFEBS Letters, 1992
- GENETICS OF HUMAN CANCERAnnual Review of Genetics, 1986